review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1097/JTO.0B013E31822944B3 |
P698 | PubMed publication ID | 21849857 |
P50 | author | Razelle Kurzrock | Q56614941 |
Ignacio Garrido-Laguna | Q71791712 | ||
Filip Janku | Q73569186 | ||
P2093 | author name string | David J Stewart | |
Lubos B Petruzelka | |||
P2860 | cites work | MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling | Q27851406 |
Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. | Q45950196 | ||
P433 | issue | 9 | |
P921 | main subject | lung cancer | Q47912 |
P304 | page(s) | 1601-1612 | |
P577 | publication date | 2011-09-01 | |
P1433 | published in | Journal of Thoracic Oncology | Q2448056 |
P1476 | title | Novel therapeutic targets in non-small cell lung cancer | |
P478 | volume | 6 |